336 results
Page 2 of 17
6-K
EX-99.1
zas3s4 gzb6i
18 Aug 16
First Intravenous Anti-IL-5 Biologic Therapy for Severe Eosinophilic Asthma Now Approved in Europe
12:00am
6-K
to9zh8y
20 Jul 16
Current report (foreign)
12:00am
424B5
effssmv4l sn1onlm
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
02r0y1j2sbfnkaqv
10 Jun 16
Teva Announces Favorable Court Ruling in TREANDA® (bendamustine hydrochloride) Patent Infringement Litigation
12:00am
6-K
EX-99.1
p8diwpbi1xsu te
18 Apr 16
First-HD Study shows improvements in Total Motor Score and Swallowing Function in Huntington disease patients treated with SD-809
12:00am
6-K
EX-99.1
rlo38vcw3hze0
12 Apr 16
Teva to Present Data Highlighting Company’s Pipeline in Neurological Disorders at 68th AAN Annual Meeting
12:00am
424B5
ezsswg1r qi6sg9h1in
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
m8hz7yrhi78n88mi
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
4htsbixh
30 Nov 15
Current report (foreign)
12:00am
6-K
zfwn7 289g2yq5ngz
30 Nov 15
Current report (foreign)
12:00am
6-K
EX-99.1
k9yurqwodvmeph4qg9f
30 Sep 15
IMPORTANT NEW DATA FROM TEVA’S TEV-48125 PHASE 2b MIGRAINE PROGRAM PUBLISHED INLANCET NEUROLOGYIN BACK-TO-BACK ARTICLES
12:00am
6-K
EX-99.1
2gzny5jpjp7udk6dj
28 Sep 15
Teva Presents New Reslizumab Data at European Respiratory Society (ERS) International Congress 2015
12:00am
6-K
EX-99.1
61279 tkd8ks
28 Sep 15
Teva Announces Approval of COPAXONE® in Japan for the Prevention of Relapse of Multiple Sclerosis
12:00am
6-K
EX-99.3
0ln6024b
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
6-K
EX-99.1
vikto cwrz
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
ox9dohdi
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
7t7xut 1o4c7tfnq0
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
02jkw
23 Mar 15
Live Filing
12:00am
6-K
EX-99.1
9cdqyj04
2 Mar 15
Teva Announces Sale of Sellersville, PA Facility
12:00am